Ontology highlight
ABSTRACT: Background
PD-1/PD-L1 immunotherapy represents the primary treatment for advanced NSCLC patients; however, response rates to this therapy vary among individuals. This dual-center study aimed to integrate habitat radiomics and multi-instance deep learning to predict durable clinical benefits from immunotherapy.Methods
We retrospectively collected 590 NSCLC patients from two medical centers who received PD-1/PD-L1 inhibitor immunotherapy. Patients from the GMU center were divided into a training cohort (n = 375) and an internal validation cohort (n = 161) for habitat analysis and multi-instance deep learning model development. Patients from the YJ center formed an external testing cohort (n = 54) for model validation. We implemented a DenseNet121-based architecture extracting
SUBMITTER: Huang X
PROVIDER: S-EPMC12272984 | biostudies-literature | 2025 Jul
REPOSITORIES: biostudies-literature